Quick Answer
BioCorRx Inc. reported Stockholders Equity of -$11.22 million for fiscal year 2025.
BioCorRx Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | -$11.22M | +7.4% |
| 2024 | -$12.12M | -23.4% |
| 2023 | -$9.82M | -21.6% |
| 2022 | -$8.08M | -16.0% |
| 2021 | -$6.96M | -65.3% |
| 2020 | -$4.21M | -297.6% |
| 2019 | -$1.06M | +81.4% |
| 2018 | -$5.71M | -46.6% |
| 2017 | -$3.89M | +52.1% |
| 2016 | -$8.13M | -147.7% |
| 2015 | -$3.28M | -1171.8% |
| 2014 | $306.3K | +37.5% |
| 2013 | $222.8K | -92.1% |
| 2012 | $2.84M | -18.7% |
| 2011 | $3.49M | +2120.5% |
| 2010 | -$172.7K | -853.0% |
| 2009 | -$18.1K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$13.48M | -14.0% | -6.8% |
| June 30, 2025 | -$12.62M | -14.8% | -9.2% |
| March 31, 2025 | -$11.56M | -7.6% | +4.7% |
| December 31, 2024 | -$12.12M | -23.4% | -2.4% |
| September 30, 2024 | -$11.83M | -29.6% | -7.5% |
| June 30, 2024 | -$11.00M | -28.2% | -2.4% |
| March 31, 2024 | -$10.74M | -23.4% | -9.3% |
| December 31, 2023 | -$9.82M | -21.6% | -7.6% |
- BioCorRx Inc. showed an increase of +7.4% in Stockholders Equity compared to the prior fiscal year.
- Over the 2009–2025 period, BioCorRx Inc.’s stockholders equity has declined by 61826.5% (from -$18.1 thousand to -$11.22 million).
- The most recent figure is from BioCorRx Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: